Literature DB >> 24645840

Nesidioblastosis in adults.

I Dravecka, I Lazurova.   

Abstract

The persistent hyperinsulinemic hypoglycemia may be caused either by a solitary tumor of the pancreas secreting excessive amount of insulin, known as insulinoma or, rarely, by nesidioblastosis. Nesidioblastosis is a rare cause of persistent hyperinsulinemic hypoglycemia in adults. The incidence of nesidioblastosis in adults is unknown, but it is generally thought to be very low. The β cell changes in adult nesidioblastosis suggest a dysregulation of the function of the cell. The cause of the functional dysregulation in adults is unknown. The pathogenesis of adult nesidioblastosis may be different from infantile congenital hyperinsulinism caused by a genetic effect. Histologically nesidioblastosis is almost always characterized by a proliferation of abnormal β cells throughout the entire pancreas. Clinically and biochemically , it is not possible to distinguish between diffuse nesidioblastosis and insulinoma. If all highly selective noninvasive imaging techiques fail to identify a tumor, selective arterial calcium stimulation testing should be performed. The final diagnosis relies on the histopathologic evaluation. The treatment of adult nesidioblastosis is surgical resection of the pancreas.

Entities:  

Mesh:

Year:  2014        PMID: 24645840     DOI: 10.4149/neo_2014_047

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  8 in total

1.  Selective Arterial Calcium Stimulation With Hepatic Venous Sampling Differentiates Insulinoma From Nesidioblastosis.

Authors:  Scott M Thompson; Adrian Vella; Geoffrey B Thompson; Kandelaria M Rumilla; F John Service; Clive S Grant; James C Andrews
Journal:  J Clin Endocrinol Metab       Date:  2015-08-27       Impact factor: 5.958

2.  Spontaneous hypoglycemia: diagnostic evaluation and management.

Authors:  Leelavathy Kandaswamy; Rajeev Raghavan; Joseph M Pappachan
Journal:  Endocrine       Date:  2016-03-07       Impact factor: 3.633

3.  Successful treatment of adult-onset nesidioblastosis by continuous subcutaneous octreotide infusion in a patient on hemodialysis.

Authors:  Rina Kato; Akihiro Nishimura; Kimio Matsumura; Shota Kikuno; Kaoru Nagasawa; Yasumichi Mori
Journal:  Clin Case Rep       Date:  2020-11-11

4.  Second MAFA Variant Causing a Phosphorylation Defect in the Transactivation Domain and Familial Insulinomatosis.

Authors:  Christian Fottner; Stefanie Sollfrank; Mursal Ghiasi; Anke Adenaeuer; Thomas Musholt; Arno Schad; Matthias Miederer; Simin Schadmand-Fischer; Matthias M Weber; Karl J Lackner; Heidi Rossmann
Journal:  Cancers (Basel)       Date:  2022-04-01       Impact factor: 6.639

5.  When a Histologic Diagnosis Becomes Factitious: A Case of Munchausen Syndrome.

Authors:  Mafalda Teixeira; Pedro Santos; Ana Bastos Furtado; José Delgado Alves
Journal:  Cureus       Date:  2022-09-07

6.  NESIDIOBLASTOSIS IN AN ADULT WITH SHORT GUT SYNDROME AND TYPE 2 DIABETES.

Authors:  Mimi Wong; Luke Conway; Caroline Cooper; Ashim Sinha; Nirjhar Nandi
Journal:  AACE Clin Case Rep       Date:  2019-08-14

7.  Nationwide survey of endogenous hyperinsulinemic hypoglycemia in Japan (2017-2018): Congenital hyperinsulinism, insulinoma, non-insulinoma pancreatogenous hypoglycemia syndrome and insulin autoimmune syndrome (Hirata's disease).

Authors:  Yuki Yamada; Kana Kitayama; Maki Oyachi; Shinji Higuchi; Rie Kawakita; Yutaka Kanamori; Tohru Yorifuji
Journal:  J Diabetes Investig       Date:  2019-12-24       Impact factor: 4.232

8.  Nesidioblastosis and Insulinoma: A Rare Coexistence and a Therapeutic Challenge.

Authors:  Angela Dardano; Giuseppe Daniele; Roberto Lupi; Niccolò Napoli; Daniela Campani; Ugo Boggi; Stefano Del Prato; Roberto Miccoli
Journal:  Front Endocrinol (Lausanne)       Date:  2020-01-24       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.